MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss

Brain Research

Volumn 1229, Issue , 2008, Pages 218-223

  Ruffoli, Riccardo ^a   Giambelluca, Maria Anita ^a   Scavuzzo, Maria Concetta ^a   Pasquali, Livia ^a   Giannessi, Francesco ^a   Fornai, Francesco ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Genital dysfunction; Leydig cells; MPTP; Norepinephrine; Parkinson's disease; Testosterone deficiency

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; NORADRENALIN; TESTOSTERONE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HORMONE DEFICIENCY; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; MALE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; TESTIS INJURY; TESTOSTERONE BLOOD LEVEL;

ANIMALS; CATECHOLAMINES; DISEASE MODELS, ANIMAL; LEYDIG CELLS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MPTP POISONING; TESTOSTERONE; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 49849095574     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.06.116     Document Type: Article

References (21)

1. Anderson G., Noorian A.R., Taylor G., Anitha M., Bernhard D., Srinivasan S., and Greene J.G. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp. Neurol. 207 (2007) 4-12
2. Anakwe O.O., and Moger W.H. β2-adrenergic stimulation of androgen production by cultured mouse testicular interstitial cells. Life Sci. 35 (1984) 2041-2047
3. Chaudhuri K.R., Healy D.G., and Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 5 (2006) 235-245
4. Davidoff M.S., Ungefroren H., Middendorff R., Koeva Y., Bakalska M., Atanassova N., Holstein A.F., Jezek D., Pusch W., and Müller D. Catecholamine-synthesizing enzymes in the adult and prenatal human testis. Histochem. Cell. Biol. 124 (2005) 313-323
5. Fornai F., Schlüter O.M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., Lazzeri G., Busceti C.L., Pontarelli F., Battaglia G., Pellegrini A., Nicoletti F., Ruggieri S., Paparelli A., and Südhof T.C. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc. Natl. Acad. Sci. USA. 102 (2005) 3413-3418
6. Gesi M., Soldani P., Giorgi F.S., Santinami A., Bonaccorsi I., and Fornai F. The role of the locus coeruleus in the development of Parkinson's disease. Neurosci. Biobehav. Rev. 24 (2000) 655-668
7. Goldstein D.S. Cardiac denervation in patients with Parkinson disease. Cleve. Clin. J. Med. 74 (2007) S91-S94
8. Javitch J.A., D'Amato R.J., Strittmatter S.M., and Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA. 82 (1985) 2173-2177
9. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
10. Langston J.W., Forno L.S., Tetrud J., Reeves A.G., Kaplan J.A., and Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46 (1999) 598-605
11. Mayerhofer A., Bartke A., and Steger R.W. Catecholamine effects on testicular testosterone production in the gonadally active and the gonadally regressed adult golden hamster. Biol. Reprod. 40 (1989) 752-761
12. Mayerhofer A., Amador A.G., Steger R.W., and Bartke A. Testicular function after local injection of 6-hydroxydopamine or norepinephrine in the golden hamster (Mesocricetus auratus). J. Androl. 11 (1990) 301-311
13. Mayerhofer A. Neuronal signalling molecules and Leydig cells. In: Totowa N.J. (Ed). Contemporary Endocrinology: The Leydig Cell in Health and Disease (2007), Humana Press Inc. 291-304
14. Okun M.S., McDonald W.M., and DeLong M.R. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. Arch. Neurol. 59 (2002) 807-811
15. Okun M.S., Walter B.L., McDonald W.M., Tenover J.L., Green J., Juncos J.L., and DeLong M.R. Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch. Neurol. 59 (2002) 1750-1753
16. Okun M.S., Fernandez H.H., Rodriguez R.L., Romrell J., Suelter M., Munson S., Louis E.D., Mulligan T., Foster P.S., Shenal B.V., Armaghani S.J., Jacobson C., Wu S., and Crucian G. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Arch. Neurol. 63 (2006) 729-735
17. Romeo R., Pellitteri R., Russo A., and Marcello M.F. Catecholaminergic phenotype of human Leydig cells. Ital. J. Anat. Embryol. 109 (2004) 45-54
18. Rommelfanger K.S., Weinshenker D., and Miller G.W. Reduced MPTP toxicity in noradrenaline transporter knockout mice. J. Neurochem. 91 (2004) 1116-1124
19. Ruffoli R., Carpi A., Giambelluca M.A., Grasso L., Scavuzzo M.C., and Giannessi F. Diazepam administration prevents testosterone decrease and lipofuscin accumulation in testis of mouse exposed to chronic noise stress. Andrologia 38 (2006) 159-165
20. Ruffoli, R., Soldani, P., Pasquali, L., Ruggieri, S., Paparelli, A., Fornai, F., in press. Methamphetamine fails to alter the noradrenergic integrity of the heart: a comparison with the parkinsonism-inducing neurotoxin MPTP. Ann. N.Y. Acad. Sci.
21. Zarow C., Lyness S.A., Mortimer J.A., and Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 60 (2003) 337-341